Skip to main content
Fig. 2 | Advances in Rheumatology

Fig. 2

From: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway

Fig. 2

Baricitinib affects lung tissue changes in mice. H&E staining and Masson staining of mouse lung tissue: a HE staining model group, ▼inflammatory cell infiltration in alveolae and the alveolar septum, septal thickening; Masson staining model group, ▼increased vascular and alveolar wall collagen deposition. b Mouse lung tissue inflammation scores (n = 3), *P < 0.05. c Mouse lung fibrosis scores (n = 3), **P < 0.01

Back to article page

Advances in Rheumatology

ISSN: 2523-3106